Internal Medicine, Endocrinology, Diabetes, & Metabolism · Seattle, WA
NPI
1982672846
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
904 7th Ave
Seattle, WA, 98104
Phone (206) 329-1760
Medicare paid, 2024
$77K
3,158 services
Medicare patients, 2024
386
Average age 73
Drug cost, 2024
$152K
4,700 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Murray was code J0897 (injection, denosumab, 1 mg), 1,140 times for 14 patients. In total Robert Murray billed 3,158 services in 28 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,140 | 14 | $19.77 | $23K |
| 84481 Clinical Chemistry | Office | 348 | 253 | $16.47 | $5,730 |
| 84443 Clinical Chemistry | Office | 346 | 250 | $16.37 | $5,663 |
| 84439 Clinical Chemistry | Office | 345 | 249 | $8.77 | $3,025 |
| 99214 Office E&M - Established | Office | 344 | 331 | $91.74 | $32K |
| 36415 Venipuncture Blood Collection | Office | 330 | 239 | $8.60 | $2,839 |
| 80053 Clinical Chemistry | Office | 69 | 57 | $10.35 | $714 |
| 83970 Clinical Chemistry | Office | 38 | 29 | $40.45 | $1,537 |
| 82306 Clinical Chemistry | Office | 32 | 25 | $29.01 | $928 |
| 99421 Office/Outpatient Services | Office | 26 | 23 | $12.47 | $324 |
| 82728 Clinical Chemistry | Office | 18 | 12 | $13.36 | $240 |
| 96372 Injection Administration | Office | 17 | 13 | $12.72 | $216 |
| 83540 Clinical Chemistry | Office | 17 | 11 | $6.34 | $108 |
| 83550 Clinical Chemistry | Office | 17 | 11 | $8.57 | $146 |
| 80061 Clinical Chemistry | Office | 13 | 13 | $13.12 | $171 |
By year: 2022 $134K for 5,273 services; 2023 $130K for 5,302 services; 2024 $77K for 3,158 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84481 Clinical Chemistry | 348 | 253 | $16.47 | $5,730 |
| 84443 Clinical Chemistry | 346 | 250 | $16.37 | $5,663 |
| 84439 Clinical Chemistry | 345 | 249 | $8.77 | $3,025 |
| 36415 Venipuncture Blood Collection | 330 | 239 | $8.60 | $2,839 |
| 80053 Clinical Chemistry | 69 | 57 | $10.35 | $714 |
| 83970 Clinical Chemistry | 38 | 29 | $40.45 | $1,537 |
| 82306 Clinical Chemistry | 32 | 25 | $29.01 | $928 |
| 82728 Clinical Chemistry | 18 | 12 | $13.36 | $240 |
| 83540 Clinical Chemistry | 17 | 11 | $6.34 | $108 |
| 83550 Clinical Chemistry | 17 | 11 | $8.57 | $146 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert Murray prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,067 prescriptions and refills. In total Robert Murray wrote 4,700 Medicare prescriptions that cost $152K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,067 | 5,880 | 605 | $21K |
| Liothyronine Sodium Generic | 1,870 | 5,277 | 575 | $92K |
| Synthroid Levothyroxine Sodium | 285 | 769 | 79 | $15K |
| Methimazole Generic | 44 | 119 | 13 | $508 |
| Alendronate Sodium Generic | 43 | 120 | 16 | $677 |
| Metformin Hcl Er Metformin Hcl | 34 | 94 | 12 | $426 |
| Levoxyl Levothyroxine Sodium | 30 | 66 | Under 11 | $1,037 |
| Cytomel Liothyronine Sodium | 29 | 71 | Under 11 | $1,416 |
| Hydrocortisone Generic | 27 | 79 | Under 11 | $1,243 |
| Rosuvastatin Calcium Generic | 27 | 81 | Under 11 | $330 |
| Calcitriol Generic | 27 | 81 | Under 11 | $1,133 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 19 | 31 | Under 11 | $141 |
| Metformin Hcl Generic | 18 | 55 | Under 11 | $205 |
| Atorvastatin Calcium Generic | 18 | 54 | Under 11 | $195 |
| Np Thyroid Thyroid,pork | 15 | 43 | Under 11 | $920 |
Brand drugs: 1,044 claims; generic drugs: 3,635 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert Murray were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.